Related Experiment Video
Updated: Dec 12, 2025

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Derivation and Validation of Novel Phenotypes of Multiple Organ Dysfunction Syndrome in Critically Ill Children
L Nelson Sanchez-Pinto1,2,3, Emily K Stroup4, Tricia Pendergrast3
1Critical Care, Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Insights
This study identified four distinct data-driven phenotypes of pediatric multiple organ dysfunction syndrome (MODS) in critically ill children, revealing significant differences in prognosis and potential therapeutic implications for each MODS phenotype.
Area of Science:
- Pediatric Critical Care Medicine
- Computational Biology
- Clinical Data Science
Background:
- Multiple organ dysfunction syndrome (MODS) presents a significant challenge in critically ill children, characterized by high morbidity and mortality.
- Understanding the heterogeneity of MODS is crucial for improving patient outcomes.
Purpose of the Study:
- To determine if data-driven phenotypes of MODS, based on organ dysfunction trajectories, possess prognostic and therapeutic relevance in pediatric intensive care.
- To identify distinct patient subgroups within MODS to guide clinical decision-making.
Main Methods:
- A cohort study analyzed 20,827 pediatric intensive care unit encounters using pediatric Sequential Organ Failure Assessment (pSOFA) scores over the first three days.
- Subgraph-augmented nonnegative matrix factorization was employed to derive data-driven MODS phenotypes from organ dysfunction trajectories.
- Phenotype membership was assessed for its association with in-hospital mortality and other clinical outcomes.
Main Results:
- Four reproducible MODS phenotypes were identified: severe persistent encephalopathy, moderate resolving hypoxemia, severe persistent hypoxemia and shock, and moderate persistent thrombocytopenia and shock.
- Each phenotype demonstrated independent prognostic value, with significant variations in mortality risk (e.g., adjusted hazard ratios ranging from 1.8 to 3.0 compared to a reference phenotype).
- Hydrocortisone treatment showed differential associations with recovery (vasoactive-free days) across phenotypes, suggesting potential therapeutic stratification.
Conclusions:
- Data-driven phenotyping successfully identified four distinct and clinically relevant phenotypes of MODS in critically ill children.
- These phenotypes offer prognostic insights and suggest potential avenues for targeted therapeutic interventions.
- Further research is warranted to validate and refine these phenotypes for clinical application.
Importance:
Multiple organ dysfunction syndrome (MODS) is a dynamic and heterogeneous process associated with high morbidity and mortality in critically ill children.
Objective:
To determine whether data-driven phenotypes of MODS based on the trajectories of 6 organ dysfunctions have prognostic and therapeutic relevance in critically ill children.
Design, Setting, And Participants:
This cohort study included 20 827 pediatric intensive care encounters among 14 285 children admitted to 2 large academic pediatric intensive care units (PICUs) between January 2010 and August 2016. Patients were excluded if they were older than 21 years or had undergone cardiac surgery. The 6 subscores of the pediatric Sequential Organ Failure Assessment (pSOFA) score were calculated for the first 3 days, including the subscores for respiratory, cardiovascular, coagulation, hepatic, neurologic, and renal dysfunctions. MODS was defined as a pSOFA subscore of at least 2 in at least 2 organs. Encounters were split in a 80:20 ratio for derivation and validation, respectively. The trajectories of the 6 subscores were used to derive a set of data-driven phenotypes of MODS using subgraph-augmented nonnegative matrix factorization in the derivation set. Data analysis was conducted from March to October 2019.
Exposures:
The primary exposure was phenotype membership. In the subset of patients with vasoactive-dependent shock, the interaction between hydrocortisone and phenotype membership and its association with outcomes were examined in a matched cohort.
Main Outcomes And Measures:
The primary outcome was in-hospital mortality. Secondary outcomes included persistent MODS on day 7, and vasoactive-free, ventilator-free, and hospital-free days. Regression analysis was used to adjust for age, severity of illness, immunocompromised status, and study site.
Results:
There were 14 285 patients with 20 827 encounters (median [interquartile range] age 5.2 years [1.5-12.7] years; 11 409 [54.8%; 95% CI, 54.1%-55.5%] male patients). Of these, 5297 encounters (25.4%; 95% CI, 24.8%-26.0%) were with patients who had MODS, of which 5054 (95.4%) met the subgraph count threshold and were included in the analysis. Subgraph augmented nonnegative matrix factorization uncovered 4 data-driven phenotypes of MODS, characterized by a combination of neurologic, respiratory, coagulation, and cardiovascular dysfunction, as follows: phenotype 1, severe, persistent encephalopathy (1019 patients [19.2%]); phenotype 2, moderate, resolving hypoxemia (1828 patients [34.5%]); phenotype 3, severe, persistent hypoxemia and shock (1012 patients [19.1%]); and phenotype 4, moderate, persistent thrombocytopenia and shock (1195 patients [22.6%]). These phenotypes were reproducible in a validation set of encounters, had distinct clinical characteristics, and were independently associated with outcomes. For example, using phenotype 2 as reference, the adjusted hazard ratios (aHRs) for death by 28 days were as follows: phenotype 1, aHR of 3.0 (IQR, 2.1-4.3); phenotype 3, aHR of 2.8 (IQR, 2.0-4.1); and phenotype 4, aHR of 1.8 (IQR, 1.2-2.6). Interaction analysis in a matched cohort of patients with vasoactive-dependent shock revealed that hydrocortisone had differential treatment association with vasoactive-free days across phenotypes. For example, patients in phenotype 3 who received hydrocortisone had more vasoactive-free days than those who did not (23 days vs 18 days; P for interaction < .001), whereas patients in other phenotypes who received hydrocortisone either had no difference or had less vasoactive-free days.
Conclusions And Relevance:
In this study, data-driven phenotyping in critically ill children with MODS uncovered 4 distinct and reproducible phenotypes with prognostic relevance and possible therapeutic relevance. Further validation and characterization of these phenotypes is warranted.
More Related Videos
09:17Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
Published on: May 2, 2017
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019